Get Indian Health Service Treatment Consent And Agreement 2017-2024

(, Contrave) must be stopped 48 hours prior surgery. is a long-acting injectable version of - if you are getting injections every month, ideally surgery should be scheduled for one month after your last injection.

Each tablet contains 50 mg of as the active ingredient. It also contains the following inactive ingredients: lactose, • hypromellose, • colloidal silicon dioxide, • magnesium stearate, • hydroxypropylcellulose, • titanium dioxide, • macrogol 8000, • iron oxide yellow, and • iron oxide red.

Talk to your healthcare provider to see if is right for you. is not right for everyone. There are significant risks from treatment, including risk of opioid overdose, severe reaction at the injection site, sudden opioid withdrawal, liver damage, or hepatitis.

, the active ingredient in , can cause liver damage or hepatitis. Tell your healthcare provider if, during treatment, you have stomach area pain lasting more than a few days, dark urine, yellowing of the whites of your eyes, or tiredness.

contains 380 mg of in a microsphere formulation per vial (337 mg of per gram of microspheres). is contraindicated in: • Patients receiving opioid analgesics [see Warnings and Precautions (5.3)].

is incorporated in 75:25 polylactide-co-glycolide (PLG) at a concentration of 337 mg of per gram of microspheres. The diluent is a clear, colorless solution. The composition of the diluent includes carboxymethylcellulose sodium salt, polysorbate 20, sodium chloride, and water for injection.